Again, the government was in a position to assess the risk profile of these devices through means other than registries.
Also, just to bring back this notion that I've indicated, it's not because they have a registry, for instance in the United States, that they are actually able to leverage the registry for the purpose of single detection and/or for the purpose of research, because of the low participation rates.
In Canada, the approach we've been taking was positive. We were able to take decisive actions in, for instance, suspending macrotextured implants when we were able to correlate the risk profile to a type of cancer.